Caris and ConcertAI have formed a partnership which hopes to combine the two vendors vast data sets and particular specialities to support the development of new drugs and therapies. However, given ConcertAI’s connection to TeraRecon, have the pair missed an opportunity in imaging?
Read the full insight with a Signify Premium Insights - Medical Imaging subscription